lindas have a posse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Added today. Shorts beware March 15.
Buying more today.
Hope you recover from that horrible experience.
Dilution isn't an issue but low volume manipulation by market makers explains the retracement.
Another Saturday night where I am very happy to be NWBO shareholder.
Congratulations to all longs!
Rent-seeking highwaymen who create no value only extract from the innovators.
Market making as practiced today needs drastic reform. Hopefully Northwest Biotherapeutics vs Citadel et al will lead to dramatic changes on Wall Street.
Another day closer to approval.
Are you ready for next week?
No doubt!
Like you I have nearly 600K shares. Congratulations!
Retired traders often go onto stock trading forums to bash companies. Nothing odd here at all.
We're going to retire early at the Four Seasons so it really doesn't matter what some rando says on this board.
⚠️ Adam Feuerstein alert! ⚠️
If each patient gets 10 doses, as they did in PIII trial, then that's 300K patients. Charge 150K per patient and we're bigger in sales than Keytruda.
Amazing 10K. Never been happier to own NWBO.
Another day closer to approval.
Are you ready for next week?
Few people understand this.
📣 Adam Feuerstein alert. 📣
Aristides Capital LLC
118 E MAIN STREET
SUITE 600
LOUISVILLE, KY 40202
Daniel Nall
Chief Compliance Officer
502-694-8001
Amazing. Thank you!
Untrue.
Contingency means shareholders are not paying for the cost of litigation.
We are approaching the stage where settlement seems probable after MTD denial.
I am also fine with a settlement if commensurate with the damage endured by shareholders as well as a punitive deterrent so this behavior stops.
Can you imagine the discoveries which have been prevented due to such illegal manipulation?
The behavior damages our economy, competitiveness internationally, as well as public health.
For that reason I hope management will move forward with the lawsuit unless a very substantial $1-2B settlement, as well as public statement of wrongdoing, can be achieved at this juncture.
Market Makers must acknowledge their grievous error unless they desire their dirty laundry shown for the public to witness.
HFT has nothing to do with the lawsuit as it isn't regarding how fast orders are placed or executed but whether they're genuine orders or fraudulent.
Humans haven't traded stock in decades while we are not complaining about statistical arbitrage or any other legitimate HFT trading strategy. The issue is criminal spoofing.
I only recall seeing Linda Powers on SEC filings.
Les sold the instrument so it should be his signature though I am unsure if this was the first time he signed 10K-NT. They haven't had one since I bought the company though I know they had issues meeting deadlines in the past.
Management cannot simply lie about the reason for filing 10K-NT unless they want jailtime before imminent MHRA approval. Seems like a bad risk reward tradeoff unless you're a psychopath.
Delay filed:
Monte Carlo simulations are used in risk models to forecast future returns from various business decisions. It's a very common model used in finance. I suspect they sold some derivative at a price based upon simulation which may now not be entirely accurate perhaps due to a change in inputs to the simulation. It will be very interesting to see the upcoming 10K in next 15 days.
https://en.m.wikipedia.org/wiki/Monte_Carlo_method
Very good point. There are numerous benefits brought by Flaskworks. I hope for approval by June after MAA approved in March - April.
Forbes are garbage. The only topic for Glioblastoma should be DCVax. The journalist who wrote this arficle is a blind jackass wondering in the woods.
Combination trial useless without Flaskworks?
DCVax has achieved 98% purity with the traditional clean room process as Dr Bosch explained in his manufacturing talk at ASCO.
Another day closer to approval.
Shorts, beware the Ides of March!
I agree which is why I have the idiots on ignore.
As we know Sawston passed inspection multiple times. Linda Powers runs a tight ship. I agree there likey won't be an RFI. Many who say the opposite forgot the company’s record of delivering results, are unfamiliar with the approval process, or wish to manipulate the stock price.
No RFI then MHRA makes determination on approval. No Phase II.
Phase II exists to address issues raised in the RFI.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173934572
In my opinion NWBO submitted a complete application without error while the exemplary data speaks for itself.
Regulators have known about DCVax for over a decade.
It was approved for use on children after approval in adults.
MHRA approved its commercial manufacturing as well as export.
No side effects.
Treats orphan disease that kills MPs, the rich, poor, the young, and the elderly.
Universal fear of Glioblastoma.
Approval only in question among those without a brain!
JFC the database on this website is fucked.
Phase II is only for RFI. Those who say otherwise are wrong.
I agree the trials should begin as soon as possible.
They can use potency assays and proteomic analysis not another trial. I don't see this as being a big deal for the handful of patients that would be in PI/II trials. It didn't stop Merck from running trials with DCVax at UCLA.
Though perhaps you are correct and we may not get notice of licensing deals, partnership, or buyout until Flaskworks gets GMP approval in UK. Though I am skeptical as the value seems already apparent.